Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SYNGENE INTERNATIONAL Plunges 6%; BSE HEALTHCARE Index Up 0.9%
Fri, 9 Aug 9:19

SYNGENE INTERNATIONAL Plunges 6%; BSE HEALTHCARE Index Up 0.9%Image source: bluebay2014/www.istockphoto.com

SYNGENE INTERNATIONAL share price has plunged 6% and is presently trading at Rs 830.0.

Meanwhile, the BSE HEALTHCARE index is at 41,279.6 (up 0.9%).

Among the top losers in the BSE HEALTHCARE index today are FDC (down 3.4%) and GLAND PHARMA (down 1.3%).

HIKAL CHEMIC (up 3.2%) and SUVEN PHARMACEUTICALS (up 2.3%) are among the top gainers today.

Over the last one year, SYNGENE INTERNATIONAL has moved down from Rs 837.9 to Rs 830.0, registering a loss of Rs 7.9 (down 0.9%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,300.0 to 41,279.6, registering a gain of 45.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 113.6%), GSK Pharma (up 107.4%) and SUVEN PHARMACEUTICALS (up 106.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,984.2 (up 1.4%).

The top gainers among the BSE Sensex today are Ultratech Cement (up 2.2%) and M&M (up 2.1%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.

In the meantime, NSE Nifty is at 24,386.9 (up 1.1%). Eicher Motor and ONGC are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,953.5 to 79,984.2, registering a gain of 14,030.8 points (up 21.3%).

SYNGENE INTERNATIONAL Financial Update...

SYNGENE INTERNATIONAL net profit fell 19.0% YoY to Rs 757 million for the quarter ended June 2024, compared to a profit of Rs 934 million a year ago. Net sales declined 2.3% to Rs 7,897 million during the period as against Rs 8,081 million in April-June 2023.

For the year ended March 2024, SYNGENE INTERNATIONAL reported 9.8% increase in net profit to Rs 5,100 million compared to net profit of Rs 4,644 million during FY23. Revenue of the company grew 9.3% to Rs 34,886 million during FY24.

The current Price to earnings ratio of SYNGENE INTERNATIONAL, based on rolling 12 month earnings, stands at 67.9.


Equitymaster requests your view! Post a comment on "SYNGENE INTERNATIONAL Plunges 6%; BSE HEALTHCARE Index Up 0.9%". Click here!